Skip to main content
Clinical Trials

A Pilot Study to Evaluate the Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal cancer (CRC) Patients with Curative Resections.

Cancer Type

Colon

ClinicalTrials.gov Identifier

NCT02891538

Principal Investigator

Sukeshi Patel Arora MD

For more information about this study
View Details

About This Study

This will be a randomized, controlled pilot trial of patients with histological documentation of primary colon or rectal adenocarcinoma with resectable cancer, who have not received any treatments for cancer. If patient is a candidate for surgical resection, with no planned neoadjuvant chemotherapy, then the patient is eligible. All eligible subjects will be consented prior to surgery.